{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:11:02Z","timestamp":1785564662721,"version":"3.56.0"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,2,7]]},"DOI":"10.18632\/oncotarget.14453","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T12:40:46Z","timestamp":1483447246000},"page":"10531-10542","source":"Crossref","is-referenced-by-count":11,"title":["Opposing roles of <i>PIK3CA<\/i> gene alterations to EZH2 signaling in non-muscle invasive bladder cancer"],"prefix":"10.18632","volume":"8","author":[{"given":"Cristina","family":"Segovia","sequence":"first","affiliation":[{"name":"Unidad de Oncolog\u00eda Molecular, CIEMAT (ed70A), Madrid, Spain"},{"name":"Grupo de Oncolog\u00eda celular y Molecular, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBER ONC), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Mart\u00ednez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Unidad de Oncolog\u00eda Molecular, CIEMAT (ed70A), Madrid, Spain"},{"name":"Grupo de Oncolog\u00eda celular y Molecular, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBER ONC), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Due\u00f1as","sequence":"additional","affiliation":[{"name":"Unidad de Oncolog\u00eda Molecular, CIEMAT (ed70A), Madrid, Spain"},{"name":"Grupo de Oncolog\u00eda celular y Molecular, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBER ONC), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Rubio","sequence":"additional","affiliation":[{"name":"Grupo de Oncolog\u00eda celular y Molecular, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBER ONC), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando F.","family":"L\u00f3pez-Calder\u00f3n","sequence":"additional","affiliation":[{"name":"Grupo de Oncolog\u00eda celular y Molecular, Hospital Universitario 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Costa","sequence":"additional","affiliation":[{"name":"Unidad de Oncolog\u00eda Molecular, CIEMAT (ed70A), Madrid, Spain"},{"name":"Unidad Mixta Roche-CHUS, Hospital Universitario de Santiago de Compostela, Traves\u00eda de Choupana, s\/n, Santiago de Compostela, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Saiz-Ladera","sequence":"additional","affiliation":[{"name":"Unidad de Oncolog\u00eda Molecular, CIEMAT (ed70A), Madrid, Spain"},{"name":"Departamento de Bioqu\u00edmica y Biolog\u00eda Molecular I, Facultad de Biolog\u00eda, Universidad Complutense, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Fern\u00e1ndez-Grajera","sequence":"additional","affiliation":[{"name":"Unidad de Oncolog\u00eda Molecular, CIEMAT (ed70A), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Duarte","sequence":"additional","affiliation":[{"name":"Grupo de Oncolog\u00eda celular y Molecular, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBER ONC), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huberto","family":"Garc\u00eda Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Servicio de Anatom\u00eda Patol\u00f3gica, Hospital Universitario 12 de Octubre, Instituto de Investigaci\u00f3n 12 de Octubre i+12, UCM, Av Cordoba s\/n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"de la Rosa","sequence":"additional","affiliation":[{"name":"Grupo de Oncolog\u00eda celular y Molecular, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBER ONC), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Villacampa","sequence":"additional","affiliation":[{"name":"Grupo de Oncolog\u00eda celular y Molecular, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBER ONC), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Castellano","sequence":"additional","affiliation":[{"name":"Grupo de Oncolog\u00eda celular y Molecular, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBER ONC), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas M.","family":"Paramio","sequence":"additional","affiliation":[{"name":"Unidad de Oncolog\u00eda Molecular, CIEMAT (ed70A), Madrid, Spain"},{"name":"Grupo de Oncolog\u00eda celular y Molecular, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBER ONC), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,1,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10555-009-9190-y","article-title":"Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications","volume":"28","author":"Chang","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"2","first-page":"36","article-title":"Non-muscle-invasive urothelial carcinoma of the bladder","volume":"63","author":"Comperat","year":"2012","journal-title":"ICUD-EAU International Consultation on Bladder Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Hurst","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10555-009-9198-3","article-title":"Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer","volume":"28","author":"Hurst","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1158\/2159-8290.CD-13-0353","article-title":"Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib","volume":"4","author":"Stack","year":"2014","journal-title":"Cancer Discov"},{"key":"6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/mc.22125","article-title":"PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors","volume":"54","author":"Real","year":"2015","journal-title":"Mol Carcinog"},{"key":"7","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1158\/0008-5472.CAN-14-1218","article-title":"In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer","volume":"74","author":"Martin","year":"2014","journal-title":"Cancer Res"},{"key":"8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13148-015-0141-x","article-title":"Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer","volume":"7","author":"de la Rosa","year":"2015","journal-title":"Clin Epigenetics"},{"key":"9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.1118947","article-title":"Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3","volume":"310","author":"Hung","year":"2005","journal-title":"Science"},{"key":"10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12864-015-1450-3","article-title":"The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies","volume":"16","author":"Theodorescu","year":"2015","journal-title":"BMC Genomics"},{"key":"11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"12","first-page":"R28","article-title":"PIK3CA mutation impact on survival in breast cancer patients and in ERalpha, PR and ERBB2-based subgroups","volume":"14","author":"Bieche","year":"2013","journal-title":"Breast Cancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1073\/pnas.0907011107","article-title":"PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer","volume":"107","author":"Gillett","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1158\/1078-0432.CCR-09-0632","article-title":"PIK3CA mutation associates with improved outcome in breast cancer","volume":"15","author":"Moynahan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/path.2601","article-title":"Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer","volume":"219","author":"Uddin","year":"2009","journal-title":"J Pathol"},{"key":"16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.1207","article-title":"Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma","volume":"198","author":"Stahl","year":"2002","journal-title":"J Pathol"},{"key":"17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00428-006-0358-3","article-title":"Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer","volume":"450","author":"Fenic","year":"2007","journal-title":"Virchows Arch"},{"key":"18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2407-12-50","article-title":"Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer","volume":"12","author":"Hou","year":"2012","journal-title":"BMC Cancer"},{"key":"19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Roberts","year":"2016","journal-title":"Nat Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"27107","DOI":"10.3390\/ijms161126000","article-title":"EZH2 in Bladder Cancer, a Promising Therapeutic Target","volume":"16","author":"Paramio","year":"2015","journal-title":"Int J Mol Sci"},{"key":"21","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer","volume":"22","author":"Helin","year":"2003","journal-title":"Embo J"},{"key":"22","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1038\/sj.onc.1207800","article-title":"Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome","volume":"23","author":"Cooper","year":"2004","journal-title":"Oncogene"},{"key":"23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ccr.2011.06.016","article-title":"Coordinated regulation of polycomb group complexes through microRNAs in cancer","volume":"20","author":"Dahiya","year":"2011","journal-title":"Cancer Cell"},{"key":"24","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1158\/0008-5472.CAN-08-3114","article-title":"The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2","volume":"69","author":"Jones","year":"2009","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/path.4032","article-title":"Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer","volume":"228","author":"Oliveira","year":"2012","journal-title":"J Pathol"},{"key":"26","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","article-title":"Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer","volume":"322","author":"Kim","year":"2008","journal-title":"Science"},{"key":"27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molcel.2011.06.020","article-title":"FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1\/KDM2B-miR-101-EZH2 pathway","volume":"43","author":"Tsichlis","year":"2011","journal-title":"Mol Cell"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Caretti, Palacios, Sartorelli, Puri. Phosphoryl-EZH-ion. Cell Stem Cell. 2011; 8:262\u20135. https:\/\/doi.org\/10.1016\/j.stem.2011.02.012.","DOI":"10.1016\/j.stem.2011.02.012"},{"key":"29","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1227604","article-title":"EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent","volume":"338","author":"Thornton","year":"2012","journal-title":"Science"},{"key":"30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ccr.2013.04.008","article-title":"Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells","volume":"23","author":"Rich","year":"2013","journal-title":"Cancer Cell"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80325","article-title":"Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma","author":"Furukawa","year":"2015","journal-title":"J Clin Invest"},{"key":"32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research N.","year":"2014","journal-title":"Nature"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016","author":"Soukup","year":"2016","journal-title":"Eur Urol"},{"key":"34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jmoldx.2015.07.008","article-title":"RNA Detection in Urine: From RNA Extraction to Good Normalizer Molecules","volume":"18","author":"Duenas","year":"2016","journal-title":"J Mol Diagn"},{"key":"35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9440(10)63110-0","article-title":"Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study","volume":"164","author":"Rodriguez-Peralto","year":"2004","journal-title":"Am J Pathol"},{"key":"36","first-page":"24","article-title":"Tissue microarray: a new technology for amplification of tissue resources","volume":"7","author":"Reiss","year":"2001","journal-title":"Cancer J"},{"key":"37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/path.1838","article-title":"Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry","volume":"207","author":"Vojtesek","year":"2005","journal-title":"J Pathol"},{"key":"38","doi-asserted-by":"publisher","first-page":"42258","DOI":"10.18632\/oncotarget.5546","article-title":"A Polycomb-mir200 loop regulates clinical outcome in bladder cancer","volume":"6","author":"Rodriguez-Peralto","year":"2015","journal-title":"Oncotarget"},{"key":"39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis","volume":"34","author":"Rezantsev","year":"2003","journal-title":"Biotechniques"},{"key":"40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Lempicki","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Mesirov","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Ma'ayan","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","author":"Gundersen","year":"2016","journal-title":"Nucleic Acids Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T16:26:45Z","timestamp":1589128005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,2]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2,7]]}},"alternative-id":["14453","28060766"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14453","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,2]]}}}